Végran et al. also reported that the anti-tumor effects of Th9 cells relied on the involvement of CD8+ T cells, but more interestingly, they found that IL-1β increased the differentiation of Th9 cells and the secretion of IL-21 via IRF1 (91). The gene discussed is IL1B; the disease is neoplasm.